ALPS Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.62M Buy
162,820
+4,623
+3% +$110K 0.02% 303
2025
Q4
$4.23M Buy
158,197
+58,383
+58% +$1.4M 0.02% 269
2025
Q3
$2.13M Sell
99,814
-12,081
-11% -$286K 0.01% 367
2025
Q2
$2.41M Sell
111,895
-28,330
-20% -$527K 0.01% 338
2025
Q1
$2.33M Buy
140,225
+5,681
+4% +$103K 0.01% 330
2024
Q4
$2.47M Buy
134,544
+7,448
+6% +$120K 0.02% 316
2024
Q3
$1.95M Sell
127,096
-1,770
-1% -$29.5K 0.01% 364
2024
Q2
$2.09M Buy
128,866
+12,644
+11% +$204K 0.01% 329
2024
Q1
$2.15M Buy
116,222
+4,489
+4% +$111K 0.02% 337
2023
Q4
$3.5M Sell
111,733
-9,077
-8% -$217K 0.03% 260
2023
Q3
$2.52M Buy
120,810
+1,274
+1% +$34.6K 0.02% 290
2023
Q2
$2.86M Buy
119,536
+12,653
+12% +$281K 0.02% 254
2023
Q1
$2.01M Sell
106,883
-2,821
-3% -$53.7K 0.02% 289
2022
Q4
$1.75M Buy
109,704
+21,338
+24% +$334K 0.02% 322
2022
Q3
$1.45M Sell
88,366
-6,118
-6% -$99.1K 0.01% 367
2022
Q2
$1.33M Sell
94,484
-71,197
-43% -$1.33M 0.01% 401
2022
Q1
$4.01M Sell
165,681
-20,363
-11% -$493K 0.04% 142
2021
Q4
$4.34M Sell
186,044
-10,850
-6% -$218K 0.05% 159
2021
Q3
$3.27M Sell
196,894
-13,285
-6% -$256K 0.03% 206
2021
Q2
$5.13M Buy
+210,179
New +$4.74M 0.05% 175
2019
Q4
Sell
-211,163
Closed -$7.6M 814
2019
Q3
$7.6M Sell
211,163
-89,587
-30% -$2.72M 0.06% 122
2019
Q2
$8.04M Buy
+300,750
New +$7.68M 0.06% 126
2017
Q4
Sell
-120,544
Closed -$4.54M 841
2017
Q3
$4.54M Buy
120,544
+10,381
+9% +$338K 0.03% 144
2017
Q2
$3.07M Buy
110,163
+5,968
+6% +$178K 0.02% 161
2017
Q1
$3.58M Sell
104,195
-12,196
-10% -$431K 0.02% 153
2016
Q4
$3.36M Sell
116,391
-36,267
-24% -$959K 0.02% 148
2016
Q3
$4.86M Buy
+152,658
New +$5.18M 0.04% 140
2016
Q1
Sell
-132,936
Closed -$4.74M 622
2015
Q4
$4.74M Sell
132,936
-24,709
-16% -$871K 0.05% 123
2015
Q3
$52.1K Buy
157,645
+58,112
+58% +$2.42M 0.05% 111
2015
Q2
$4.17M Buy
99,533
+49,968
+101% +$1.93M 0.04% 128
2015
Q1
$1.61M Buy
+49,565
New +$1.7M 0.01% 160

Other funds holding ACAD